|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 4 863-R869, Copyright © 1996 by American Physiological Society
ARTICLES |
M. A. Carroll, M. Balazy, P. Margiotta, D. D. Huang, J. R. Falck and J. C. McGiff
Department of Pharmacology, New York Medical College, Valhalla 10595, USA.
The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to omega- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and 20-hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys were perfused with Krebs-Henseleit solution containing indomethacin (2.8 microM) to prevent further metabolism of HETEs by cyclooxygenase. Phenylephrine (2-3 microM) was added to the perfusate to raise perfusion pressure to approximately 80 mmHg. Angiotensin II (ANG II), arginine vasopressin (AVP), and bradykinin (BK) were injected into the renal artery and perfusates collected throughout the vasoactive response. After addition of an internal standard, deuterated 19-HETE, perfusates were extracted and purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270 pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE release associated with an increase of 40 +/- 11 mmHg in perfusion pressure. An equipressor dose of AVP (50 ng) did not release P-450 HETEs nor did a 5-micrograms dose of the vasodilator peptide BK, which decreased perfusion pressure by 22 +/- 6 mmHg. Authentic 19- and 20-HETE isomers resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas their enantiomers and 17-HETE isomers were without effect on perfusion pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and 19-HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs exhibited both regio- and stereoselective inhibition of proximal tubule adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and 17-HETE potently inhibited activity, whereas their (R) isomers and other P-450 HETEs had negligible effects on ATPase activity. The quantity of HETEs released from the kidney, either under basal conditions or when stimulated by ANG II, and their biological profile suggest that subterminal HETEs may participate in renal mechanisms affecting vasomotion and tubular transport.
This article has been cited by other articles:
![]() |
L. Magnusson, C. M. Sorensen, T. H. Braunstein, N.-H. Holstein-Rathlou, and M. Salomonsson Renovascular BKCa channels are not activated in vivo under resting conditions and during agonist stimulation Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R345 - R353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids Am J Physiol Renal Physiol, August 1, 2005; 289(2): F386 - F392. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Oyekan Differential Effects of 20-Hydroxyeicosatetraenoic Acid on Intrarenal Blood Flow in the Rat J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1289 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Rajapakse, R. J. Roman, J. R. Falck, J. J. Oliver, and R. G. Evans Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R181 - R187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Cheng, J. C. McGiff, and M. A. Carroll Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase Am J Physiol Renal Physiol, March 1, 2003; 284(3): F474 - F479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-M. Gu and W.-H. Wang Arachidonic acid inhibits K channels in basolateral membrane of the thick ascending limb Am J Physiol Renal Physiol, September 1, 2002; 283(3): F407 - F414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alonso-Galicia, K. G. Maier, A. S. Greene, A. W. Cowley Jr., and R. J. Roman Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R60 - R68. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Tsao, S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot, J. A. Goldstein, and D. C. Zeldin Identification and Localization of Five CYP2Cs in Murine Extrahepatic Tissues and Their Metabolism of Arachidonic Acid to Regio- and Stereoselective Products J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 39 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bautista, A. Sanchez, J. Hernandez, A. Oyekan, and B. Escalante Angiotensin II Type AT2 Receptor mRNA Expression and Renal Vasodilatation Are Increased in Renal Failure Hypertension, September 1, 2001; 38(3): 669 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Fallet, J. P. Bast, K. Fujiwara, N. Ishii, S. C. Sansom, and P. K. Carmines Influence of Ca2+-activated K+ channels on rat renal arteriolar responses to depolarizing agonists Am J Physiol Renal Physiol, April 1, 2001; 280(4): F583 - F591. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Carroll and J. C McGiff A new class of lipid mediators: cytochrome P450 arachidonate metabolites Thorax, October 1, 2000; 55(90002): 13S - 16. [Full Text] |
||||
![]() |
K. D. Croft, J. C. McGiff, A. Sanchez-Mendoza, and M. A. Carroll Angiotensin II releases 20-HETE from rat renal microvessels Am J Physiol Renal Physiol, September 1, 2000; 279(3): F544 - F551. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Tsao, J. Foley, S. J. Coulter, R. Maronpot, D. C. Zeldin, and J. A. Goldstein CYP2C40, a Unique Arachidonic Acid 16-Hydroxylase, Is the Major CYP2C in Murine Intestinal Tract Mol. Pharmacol., August 1, 2000; 58(2): 279 - 287. [Abstract] [Full Text] |
||||
![]() |
J. C. Frisbee, J. R. Falck, and J. H. Lombard Contribution of cytochrome P-450 omega -hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1517 - H1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text] |
||||
![]() |
J. C. McGiff and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qu, R. A. Rippe, J. Ma, P. Scarborough, C. Biagini, F. T. Fiedorek, G. S. Travlos, C. Parker, and D. C. Zeldin Nutritional Status Modulates Rat Liver Cytochrome P450 Arachidonic Acid Metabolism Mol. Pharmacol., September 1, 1998; 54(3): 504 - 513. [Abstract] [Full Text] |
||||
![]() |
A. O. Oyekan and J. C. McGiff Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R52 - R61. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lange, D. Gebremedhin, J. Narayanan, and D. Harder 20-Hydroxyeicosatetraenoic Acid-induced Vasoconstriction and Inhibition of Potassium Current in Cerebral Vascular Smooth Muscle Is Dependent on Activation of Protein Kinase C J. Biol. Chem., October 24, 1997; 272(43): 27345 - 27352. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qu, J. A. Bradbury, C.-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al. Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain J. Biol. Chem., June 29, 2001; 276(27): 25467 - 25479. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |